Tandem Diabetes Care, Inc. announced that its t:slim Mobile App has received authorization from Health Canada for use with both iPhone and Android phones. This regulatory approval allows Canadian customers to access the mobile application, which provides control and data viewing capabilities for their insulin pumps. The app is expected to be available for Canadian customers later this year.
The authorization of the t:slim Mobile App for both major smartphone platforms enhances the user experience by offering greater convenience and flexibility in managing diabetes. This development is part of Tandem's ongoing efforts to expand its digital health ecosystem and provide comprehensive solutions to its global customer base.
This milestone in Canada follows similar advancements in other markets and underscores Tandem's commitment to integrating its insulin delivery systems with modern mobile technology. The app's availability will allow users to manage their t:slim X2 and Tandem Mobi systems directly from their smartphones.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.